Iterum Therapeutics Plc (ITRM) Tops Q2 EPS by 2c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q2 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital